pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-216b |
Genomic Coordinates | chr2: 56000714 - 56000795 |
Description | Homo sapiens miR-216b stem-loop |
Comment | This sequence was identified as a miRNA candidate by Berezikov et al. using RAKE and MPSS techniques . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-216b-5p | |||||||||||||||||||||||||||||||||
Sequence | 11| AAAUCUCUGCAGGCAAAUGUGA |32 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DNAJB9 | ||||||||||||||||||||
Synonyms | ERdj4, MDG-1, MDG1, MST049, MSTP049 | ||||||||||||||||||||
Description | DnaJ heat shock protein family (Hsp40) member B9 | ||||||||||||||||||||
Transcript | NM_012328 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DNAJB9 | |||||||||||||||||||||
3'UTR of DNAJB9 (miRNA target sites are highlighted) |
>DNAJB9|NM_012328|3'UTR 1 TTCTTATTCTATTCTCACTAAATCCAACTGGTTGACTCTTCCTCATTATCTTTGATGCTAAACAATTTTCTGTGAACTAT 81 TTTGACAAGTGCATGATTTCACTTTAAACAATTTGATATAGCTATTAAATATATTTAAGGGTTTTTTTTTTTTGACAAAT 161 TCAACATTCAACGAGTAGACAAAATGCTAATTATTTCCCTGATTAGGAAAGTTTCTTTAAAAAACACGTAATTTTGCCTA 241 GTGCTTTTTCTCTACCTGCCCTTGGGCTCACTAATATCACCAGTATTATTACCAAGAAAATATTGAGTTTACCTGATTAA 321 ACTTTAAAAGTTAATTGTAGATTTAAATTGTGTGAACCTAATGATTTTTGCAGTGAAACCTTTACTAATTCAAAGTTGCA 401 TGTTCTATGACATCTGTGACTTGCGTTGCAGAGTGTACATGAAACTGTATAATTGAGTCATTCAGTAAAGGAGAACAGTA 481 TCTTGGTTAATTGCTACTGAAAGGTTGAGAAAGGAATGGTTTGATATTTACCACAGCGCTGTGCCTTTCTACAGTAGAAC 561 TGGGGTAAAGGAAATGGTTTTATTGCCCATAGTCATTTAGGCTGGAAAAAAGTTGAAAACTTAACGAAATATTGCCAAGA 641 GATTGTTATGTGTTTGGTTCCAGCCTAAAAATGATTTTGTAGTGTTGAAATCATAGCTACTTACATAGCTTTTTCATATT 721 TCTTTCTTAGTTGTTGGCACTCTTAGGTCTTAGTATGGATTTATGTGTTTGTGTGTGTGTAGTTTATCCTCTCTCTCATC 801 TTTATCTAGAGATTGACTGATACCTCATTCTGTTTGTAAAACCAGCCAGTAATTTCTGTGCAACCTTACTATGTGCAATA 881 TTTTTAAATCCTGAGAAATGTGTGCTTTTGTTTTCGGATAGACTTATTTCTTTAGTTCTGCACTTTTCCACATTATACTC 961 CATATGAGTATTAATCCTATGGATACATATTAAAACAAGTGTCTCATACAACATTGTATGTGAGAGAAATATAAATATTT 1041 ACAACCTGATATTCGTTGTTGTTTTATTGTTAAAAGTTTATTATGCAACTCTGGAGGTATAGAGGGCATATAAGCTATGG 1121 GACATATGCTGATCACAGGCTATATTCATGAAGTTACTTTTGACCAACCTGAAAACTGATAGGATTTTGTTTGTCATTTG 1201 GTAATTTCTACTGCATTCTTACCATCCTTCTCTCACAAATTTTGATAGCTTGAAGATCTTTTTAATTATAATTTTGTTGT 1281 ATTTGTTTCCTAGGAGCAAGTGTTCCTGCTGCCAGTTCTTTCCTCTTTAGGCGTGGTTGAGAAAAAGCAGAAACTTTACA 1361 TAAAGCTGTATTTCTTAATCATCTTTAATTTGAAACTTAAGAAAATGAATTTATTCTGTTATATTTATGTAACTTATTTC 1441 CTGGAAGTTATATCTACTAGTTTTGTTTGATAATAATAAAATTAGCTATACCTTGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 4189.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000249356.3 | 3UTR | UUUAUCCUCUCUCUCAUCUUUAUCUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000249356.3 | 3UTR | UUAUCCUCUCUCUCAUCUUUAUCUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000249356.3 | 3UTR | UUUAUCCUCUCUCUCAUCUUUAUCUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
129 hsa-miR-216b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006144 | KRAS | KRAS proto-oncogene, GTPase | 3 | 1 | ||||||||
MIRT007207 | CSNK2A1 | casein kinase 2 alpha 1 | 3 | 1 | ||||||||
MIRT064260 | KIAA1804 | mitogen-activated protein kinase kinase kinase 21 | 2 | 2 | ||||||||
MIRT169957 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 6 | ||||||||
MIRT362970 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT437983 | BECN1 | beclin 1 | 3 | 2 | ||||||||
MIRT443073 | ABLIM1 | actin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT443747 | ZFAND5 | zinc finger AN1-type containing 5 | 2 | 6 | ||||||||
MIRT445488 | KLF12 | Kruppel like factor 12 | 2 | 2 | ||||||||
MIRT447818 | ZCCHC11 | zinc finger CCHC-type containing 11 | 2 | 2 | ||||||||
MIRT448753 | HINT1 | histidine triad nucleotide binding protein 1 | 2 | 2 | ||||||||
MIRT460391 | GUF1 | GUF1 homolog, GTPase | 2 | 2 | ||||||||
MIRT466481 | TECPR2 | tectonin beta-propeller repeat containing 2 | 2 | 7 | ||||||||
MIRT472205 | NGFRAP1 | brain expressed X-linked 3 | 2 | 4 | ||||||||
MIRT473269 | MID1 | midline 1 | 2 | 2 | ||||||||
MIRT489831 | P2RY2 | purinergic receptor P2Y2 | 2 | 2 | ||||||||
MIRT497753 | OXGR1 | oxoglutarate receptor 1 | 2 | 2 | ||||||||
MIRT502881 | CDK4 | cyclin dependent kinase 4 | 2 | 8 | ||||||||
MIRT505904 | RIMS3 | regulating synaptic membrane exocytosis 3 | 2 | 6 | ||||||||
MIRT506657 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 4 | ||||||||
MIRT510190 | MON1B | MON1 homolog B, secretory trafficking associated | 2 | 4 | ||||||||
MIRT512406 | CD84 | CD84 molecule | 2 | 2 | ||||||||
MIRT520342 | UBXN2A | UBX domain protein 2A | 2 | 2 | ||||||||
MIRT523602 | FZD5 | frizzled class receptor 5 | 2 | 2 | ||||||||
MIRT529598 | C6orf132 | chromosome 6 open reading frame 132 | 2 | 2 | ||||||||
MIRT534444 | SDR16C5 | short chain dehydrogenase/reductase family 16C member 5 | 2 | 2 | ||||||||
MIRT534739 | RBM47 | RNA binding motif protein 47 | 2 | 2 | ||||||||
MIRT537285 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT546979 | PRKAB2 | protein kinase AMP-activated non-catalytic subunit beta 2 | 2 | 2 | ||||||||
MIRT549862 | MCM4 | minichromosome maintenance complex component 4 | 2 | 2 | ||||||||
MIRT552535 | ZIC5 | Zic family member 5 | 2 | 2 | ||||||||
MIRT555322 | PPP2CB | protein phosphatase 2 catalytic subunit beta | 2 | 2 | ||||||||
MIRT555661 | PGM3 | phosphoglucomutase 3 | 2 | 2 | ||||||||
MIRT559128 | C11orf57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT567802 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT567866 | DCAF12 | DDB1 and CUL4 associated factor 12 | 2 | 2 | ||||||||
MIRT574661 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT575029 | Tecpr2 | tectonin beta-propeller repeat containing 2 | 2 | 5 | ||||||||
MIRT607227 | ACSM2A | acyl-CoA synthetase medium chain family member 2A | 2 | 4 | ||||||||
MIRT609385 | FAM216B | family with sequence similarity 216 member B | 2 | 4 | ||||||||
MIRT612266 | PDZD4 | PDZ domain containing 4 | 2 | 2 | ||||||||
MIRT617434 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 4 | ||||||||
MIRT619453 | NUP214 | nucleoporin 214 | 2 | 2 | ||||||||
MIRT620242 | CCDC65 | coiled-coil domain containing 65 | 2 | 2 | ||||||||
MIRT620463 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT620909 | MUT | methylmalonyl-CoA mutase | 2 | 2 | ||||||||
MIRT621006 | C19orf52 | translocase of inner mitochondrial membrane 29 | 2 | 2 | ||||||||
MIRT621568 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT622059 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT622132 | SP4 | Sp4 transcription factor | 2 | 2 | ||||||||
MIRT623365 | LZIC | leucine zipper and CTNNBIP1 domain containing | 2 | 2 | ||||||||
MIRT624370 | CDK12 | cyclin dependent kinase 12 | 2 | 2 | ||||||||
MIRT627944 | NNT | nicotinamide nucleotide transhydrogenase | 2 | 2 | ||||||||
MIRT628228 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT630150 | ZDHHC9 | zinc finger DHHC-type containing 9 | 2 | 2 | ||||||||
MIRT630237 | SORD | sorbitol dehydrogenase | 2 | 2 | ||||||||
MIRT631271 | CENPM | centromere protein M | 2 | 2 | ||||||||
MIRT637456 | ZNF324B | zinc finger protein 324B | 2 | 2 | ||||||||
MIRT637899 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT641610 | CAPN7 | calpain 7 | 2 | 2 | ||||||||
MIRT643088 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT643813 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT643911 | TCEB2 | elongin B | 2 | 2 | ||||||||
MIRT644900 | ZBED1 | zinc finger BED-type containing 1 | 2 | 2 | ||||||||
MIRT645012 | NGRN | neugrin, neurite outgrowth associated | 2 | 2 | ||||||||
MIRT645521 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT646032 | S100A7A | S100 calcium binding protein A7A | 2 | 2 | ||||||||
MIRT646626 | CENPL | centromere protein L | 2 | 2 | ||||||||
MIRT646721 | RHOG | ras homolog family member G | 2 | 2 | ||||||||
MIRT647196 | ZNF583 | zinc finger protein 583 | 2 | 2 | ||||||||
MIRT648010 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT648362 | AKIP1 | A-kinase interacting protein 1 | 2 | 2 | ||||||||
MIRT648400 | WRN | Werner syndrome RecQ like helicase | 2 | 2 | ||||||||
MIRT648833 | C8orf37 | chromosome 8 open reading frame 37 | 2 | 2 | ||||||||
MIRT651870 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT652490 | TMEM178B | transmembrane protein 178B | 2 | 2 | ||||||||
MIRT652529 | TM9SF4 | transmembrane 9 superfamily member 4 | 2 | 2 | ||||||||
MIRT652536 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 2 | ||||||||
MIRT652795 | TCEANC2 | transcription elongation factor A N-terminal and central domain containing 2 | 2 | 2 | ||||||||
MIRT653379 | SMAD1 | SMAD family member 1 | 2 | 2 | ||||||||
MIRT655568 | P2RX7 | purinergic receptor P2X 7 | 2 | 2 | ||||||||
MIRT657235 | IER5 | immediate early response 5 | 2 | 2 | ||||||||
MIRT657594 | GRIN2A | glutamate ionotropic receptor NMDA type subunit 2A | 2 | 2 | ||||||||
MIRT658037 | FZD9 | frizzled class receptor 9 | 2 | 2 | ||||||||
MIRT658151 | FGF10 | fibroblast growth factor 10 | 2 | 2 | ||||||||
MIRT658459 | FAM117B | family with sequence similarity 117 member B | 2 | 2 | ||||||||
MIRT658503 | EXOC5 | exocyst complex component 5 | 2 | 2 | ||||||||
MIRT659420 | COL4A4 | collagen type IV alpha 4 chain | 2 | 2 | ||||||||
MIRT660023 | C1GALT1 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT660032 | C16orf52 | chromosome 16 open reading frame 52 | 2 | 2 | ||||||||
MIRT661206 | MPPE1 | metallophosphoesterase 1 | 2 | 2 | ||||||||
MIRT661639 | UGT2B28 | UDP glucuronosyltransferase family 2 member B28 | 2 | 2 | ||||||||
MIRT665303 | ZBTB38 | zinc finger and BTB domain containing 38 | 2 | 2 | ||||||||
MIRT668010 | HCFC2 | host cell factor C2 | 2 | 2 | ||||||||
MIRT673436 | APAF1 | apoptotic peptidase activating factor 1 | 2 | 2 | ||||||||
MIRT673583 | KDELC2 | KDEL motif containing 2 | 2 | 2 | ||||||||
MIRT673717 | SLU7 | SLU7 homolog, splicing factor | 2 | 2 | ||||||||
MIRT674315 | IMP4 | IMP4, U3 small nucleolar ribonucleoprotein | 2 | 2 | ||||||||
MIRT675811 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT686564 | TPM3 | tropomyosin 3 | 2 | 2 | ||||||||
MIRT687134 | QPCTL | glutaminyl-peptide cyclotransferase like | 2 | 2 | ||||||||
MIRT687463 | NKD1 | naked cuticle homolog 1 | 2 | 2 | ||||||||
MIRT690226 | C5orf45 | MRN complex interacting protein | 2 | 2 | ||||||||
MIRT690532 | ZNF566 | zinc finger protein 566 | 2 | 2 | ||||||||
MIRT693077 | AS3MT | arsenite methyltransferase | 2 | 2 | ||||||||
MIRT694083 | RNASEH2B | ribonuclease H2 subunit B | 2 | 2 | ||||||||
MIRT695388 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT695638 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT696540 | C3 | complement C3 | 2 | 2 | ||||||||
MIRT705522 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 2 | 2 | ||||||||
MIRT711304 | ACOX1 | acyl-CoA oxidase 1 | 2 | 2 | ||||||||
MIRT711513 | ESCO1 | establishment of sister chromatid cohesion N-acetyltransferase 1 | 2 | 2 | ||||||||
MIRT711617 | LHX5 | LIM homeobox 5 | 2 | 2 | ||||||||
MIRT711647 | LIPG | lipase G, endothelial type | 2 | 2 | ||||||||
MIRT711771 | CCDC59 | coiled-coil domain containing 59 | 2 | 2 | ||||||||
MIRT713207 | SOCS6 | suppressor of cytokine signaling 6 | 2 | 2 | ||||||||
MIRT715047 | PRPF38A | pre-mRNA processing factor 38A | 2 | 2 | ||||||||
MIRT715620 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT717677 | CDC42BPA | CDC42 binding protein kinase alpha | 2 | 2 | ||||||||
MIRT718016 | METTL15 | methyltransferase like 15 | 2 | 2 | ||||||||
MIRT721251 | KIAA0922 | transmembrane 131 like | 2 | 2 | ||||||||
MIRT721438 | ARPC4 | actin related protein 2/3 complex subunit 4 | 2 | 2 | ||||||||
MIRT722193 | DNAJC9 | DnaJ heat shock protein family (Hsp40) member C9 | 2 | 2 | ||||||||
MIRT723319 | PRKCH | protein kinase C eta | 2 | 2 | ||||||||
MIRT725299 | NLRC5 | NLR family CARD domain containing 5 | 2 | 2 | ||||||||
MIRT731866 | HDAC8 | histone deacetylase 8 | 3 | 1 | ||||||||
MIRT731987 | PARP1 | poly(ADP-ribose) polymerase 1 | 3 | 1 | ||||||||
MIRT735558 | MALAT1 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | 3 | 0 | ||||||||
MIRT735826 | SMAD3 | SMAD family member 3 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|